Multicenter Study on the Long-Term (3-Year) Efficacy of Lanthanum Carbonate in Dialysis Patients

被引:0
|
作者
Ando, Ryoichi [1 ]
Yama, Satomi [1 ]
Ohnishi, Tsuyoshi [1 ]
Iwamoto, Shunsuke [1 ]
Kimura, Hitoshi [1 ]
Chida, Yoshiko [2 ]
Ishida, Yuji [3 ]
Yamada, Kouei [4 ]
Inagaki, Yuichiro [4 ]
Takayama, Masanobu [5 ]
Tachibana, Ken [6 ]
Kikuchi, Kan [7 ]
Inoue, Atsushi [7 ]
Ohtsuka, Masakazu [8 ]
机构
[1] Musashino Red Cross Hosp, Dept Nephrol, Tokyo, Japan
[2] Nakano Clin, Tokyo, Japan
[3] Kyonan Clin, Tokyo, Japan
[4] Kichijoji Ekimae Clin, Tokyo, Japan
[5] Takayama Clin, Tokyo, Japan
[6] Tachibana Clin, Tokyo, Japan
[7] Shimo Ochiai Clin, Tokyo, Japan
[8] Tokiwa Clin, Toride, Ibaraki, Japan
关键词
Lanthanum Carbonate; Long-Term Effects; Management Target Values; Multicenter Study; CHRONIC KIDNEY-DISEASE; MORTALITY RISK; SERUM-CALCIUM; HEMODIALYSIS-PATIENTS; PHOSPHATE; HYPERPHOSPHATEMIA; PTH;
D O I
10.1111/1744-9987.12206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We previously conducted a multicenter study enrolling 101 dialysis patients with hyperphosphatemia in which lanthanum carbonate (LC) was administered for 2 years. In this study, the administration has been continued for an additional year, and we have evaluated the long-term (a total of 3 years) effects of LC. The average serum phosphorus (P) level was 6.05 mg/dL at the start and decreased to 5.84 mg/dL after 3 years, but no significant differences were observed at both points. The average serum corrected calcium (Ca) level significantly reduced after 3 years (P < 0.001). As results of evaluating the achievement rates with the management target values of serum P, Ca and intact parathyroid hormone (PTH) stated in the Japanese guideline, the achievement rates increased after 3 years. From these results, LC is considered to be a useful P binder that can be used for long-term treatment of hyperphosphatemia, without causing a Ca load.
引用
收藏
页码:2 / 8
页数:7
相关论文
共 50 条
  • [11] LONG-TERM EFFICACY AND SAFETY OF ALPHA 1-BLOCKER NAFTOPIDIL FOR PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA: 3-YEAR OUTCOME ANALYSIS OF A PROSPECTIVE MULTICENTER STUDY
    Masumori, Naoya
    Tsukamoto, Taiji
    JOURNAL OF UROLOGY, 2014, 191 (04): : E671 - E671
  • [12] IS SULFONYLUREA THERAPY EFFECTIVE LONG-TERM - A 3-YEAR STUDY WITH GLICLAZIDE
    HERNANDEZ, JZ
    LAVIELLE, R
    CURRENT MEDICAL RESEARCH AND OPINION, 1986, 10 (05) : 351 - 358
  • [13] A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients
    D'Haese, PC
    Spasovski, GB
    Sikole, A
    Hutchison, A
    Freemont, TJ
    Sulkova, S
    Swanepoel, C
    Pejanovic, S
    Djukanovic, L
    Balducci, A
    Coen, G
    Sulowicz, W
    Ferreira, A
    Torres, A
    Curic, S
    Popovic, M
    Dimkovic, N
    De Broe, ME
    KIDNEY INTERNATIONAL, 2003, 63 : S73 - S78
  • [14] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: 3-year Results from the SELECT-EARLY Study
    van Vollenhoven, Ronald F.
    Takeuchi, Tsutomu
    Aelion, Jacob
    Chavez, Nilmo
    Mannucci, Pablo
    Singhal, Atul
    Swierkot, Jerzy
    Friedman, Alan
    Khan, Nasser
    Li, Yihan
    Bu, Xianwei
    Klaff, Justin
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3527 - 3530
  • [15] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: 3-YEAR RESULTS FROM THE SELECT-EARLY STUDY
    van Vollenhoven, R.
    Takeuchi, T.
    Aelion, J.
    Chavez, N.
    Mannucci Walter, P.
    Singhal, A.
    Swierkot, J.
    Friedman, A.
    Khan, N.
    Li, Y.
    Bu, X.
    Klaff, J.
    Strand, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 568 - 569
  • [16] Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
    Shimizu, Hiromichi
    Aonuma, Yuko
    Hibiya, Shuji
    Kawamoto, Ami
    Takenaka, Kento
    Fujii, Toshimitsu
    Saito, Eiko
    Nagahori, Masakazu
    Ohtsuka, Kazuo
    Okamoto, Ryuichi
    INTESTINAL RESEARCH, 2024, 22 (03) : 369 - 377
  • [17] Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
    Kuba, R.
    Novotna, I.
    Brazdil, M.
    Kocvarova, J.
    Tyrlikova, I.
    Mastik, J.
    Rektor, I.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 121 (02): : 83 - 88
  • [18] A Nodular Foreign Body Reaction in a Dialysis Patient Receiving Long-term Treatment With Lanthanum Carbonate
    Valika, Aziz K.
    Jain, Dhanpat
    Jaffe, Phillip E.
    Moeckel, Gilbert
    Brewster, Ursula C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (01) : 128 - 132
  • [19] Long-term safety and efficacy of renal sympathetic denervation in atrial fibrillation: 3-year results of the AFFORD study
    Zeijen, Victor J. M.
    Theuns, Dominic A.
    Feyz, Lida
    Saville, Kari A.
    Bhagwandien, Rohit
    Kardys, Isabella
    Van Mieghem, Nicolas M.
    Daemen, Joost
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (12) : 1766 - 1777
  • [20] Long-term safety and efficacy of renal sympathetic denervation in atrial fibrillation: 3-year results of the AFFORD study
    Victor J. M. Zeijen
    Dominic A. Theuns
    Lida Feyz
    Kari A. Saville
    Rohit Bhagwandien
    Isabella Kardys
    Nicolas M. Van Mieghem
    Joost Daemen
    Clinical Research in Cardiology, 2023, 112 : 1766 - 1777